Neurocrine Biosciences
NBIX
#1345
Rank
NZ$23.34 B
Marketcap
$230.58
Share price
5.02%
Change (1 day)
19.05%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of September 2024 : NZ$4.71 Billion

According to Neurocrine Biosciences 's latest financial reports the company has NZ$4.71 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$3.52 B31.21%
2022-12-31$NZ$2.68 B33.72%
2021-12-31$NZ$2.01 B28.88%
2020-12-31$NZ$1.56 B65.05%
2019-12-31$NZ$0.94 B31.94%
2018-12-31$NZ$0.71 B36.78%
2017-12-31$NZ$0.52 B15.27%
2016-12-31$NZ$0.45 B-26.7%
2015-12-31$NZ$0.62 B132.83%
2014-12-31$NZ$0.26 B81.78%
2013-12-31$NZ$0.14 B-21.92%
2012-12-31$NZ$0.18 B143.76%
2011-12-31$NZ$76.98 M207.01%
2010-12-31$NZ$25.07 M360.61%
2009-12-31$NZ$5.44 M-91.41%
2008-12-31$NZ$63.36 M-59.11%
2007-12-31$NZ$0.15 B-65.31%
2006-12-31$NZ$0.44 B-21.73%
2005-12-31$NZ$0.57 B3.41%
2004-12-31$NZ$0.55 B-8.27%
2003-12-31$NZ$0.60 B40.42%
2002-12-31$NZ$0.42 B-42.67%
2001-12-31$NZ$0.74 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$3.49 B-25.83%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.77 B 277.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
-NZ$13.32 Million-100.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$24.81 B 426.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.52 B 123.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$160.40 B 3,304.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.74 B-84.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$63.08 Million-101.34%๐Ÿ‡บ๐Ÿ‡ธ USA